Treatment of inflammation and prevention of infection associated
with cataract surgery
Dose and Duration
▼
Treatment of inflammation and prevention of infection associated
with cataract surgery
Adult and child ≥ 2 years:0. instil 1 drop in
the eyes every 4–6 hours while patient is awake for 14 days (max
24 days). Dosage may be increased to 1 drop every 2 hours while
patient is awake during the first 24–48 hours.
Decrease dosing frequency gradually with improvement
Contraindications
▼
Herpes simplex keratitis and other viral eye diseases
Fungal disease of the eye
Mycobacterial infections of the eye
Untreated purulent infections
Hypersensitivity to dexamethasone or tobramycin
Side Effects
▼
Nausea, dyspepsia
Hypersensitivity reactions
Irritation at injection site
Inhibition of growth in children ( on long term use)
Cushing syndrome (on long term use)
Stinging, burning, redness, watering of eyes and increased
intraocular pressure (longer than 2 weeks treatment) in ocular
application
Interactions
▼
Live vaccines (no effect of vaccines due to impaired immune
response)
Insulin (reduced effect of insulin)
Amphotericin B (increased risk of hypokalaemia)
Carbamazepine, rifampicin, phenytoin, phenobarbital (reduced
effect of dexamethasone)
Lopinavir (reduced concentration of lopinavir)
Methotrexate (increased risk of blood disorders)
Patient Instructions
▼
Do not use this medication for more than 1 week unless you have
consulted your ophthalmologist
Do not wear contact lenses during the treatment period
In case of transient blurring of vision, do not operate
hazardous machinery or drive until vision is clear
Keep bottle tightly closed. Do not let the dropper tip touch any
surface to minimise risk of infection
Pregnancy
▼
Can be used
Breastfeeding
▼
Can be used
⚠️ Caution
▼
Use with caution in patients with glaucoma or a family history
of glaucoma
Do not use for longer than 1 week unless under ophthalmic
supervision; prolonged use may lead to a rise in intraocular
pressure and secondary ocular infections